Published in Medical Devices and Surgical Technology Week, September 9th, 2007
For the second quarter of 2007, the company reported revenues of $0.7 million and a net loss of $7.1 million. As of June 30, 2007, cash and cash equivalents totaled $58.9 million, which included net proceeds from the private equity offering that closed in June 2007. For the second quarter of 2007, net loss included stock compensation expense of $4.1 million...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.